Stay updated on LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Sign up to get notified when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.

Latest updates to the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and notices including 'Notice Because of a lapse in government funding...' and 'Revision: v3.4.1' were removed from the history; the rest of the study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a site-wide funding notice banner and the revision tag Revision: v3.4.1; removed the previous Revision: v3.4.0 tag.SummaryDifference0.7%

- Check28 days agoChange DetectedThe page adds a glossary display option and uses green/red highlights to show additions and deletions; there are small textual tweaks such as capitalization of the No FEAR Act data label and the revision tag updated to v3.4.0.SummaryDifference0.8%

- Check42 days agoChange DetectedThe screenshot shows Revision: v3.3.4 added and Revision: v3.3.3 removed, indicating a minor UI/version update with no changes to study details.SummaryDifference0.1%

- Check64 days agoChange DetectedNew revision entry v3.3.3 has been added to the history. The HHS Vulnerability Disclosure link and the v3.3.2 revision entry have been removed from the footer.SummaryDifference0.2%

- Check92 days agoChange DetectedAdded a new revision entry, Revision: v3.3.2, and removed the previous Revision: v3.2.0 from the Study Record Versions list.SummaryDifference0.1%

Stay in the know with updates to LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Enter your email address, and we'll notify you when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.